• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • COVID-19
  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • Artificial Intelligence
    • Blockchain
    • Mobile Health
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

Cedars-Sinai, Emulate Partner on ‘Patient-on-a-Chip’ Program to Predict Disease Treatments

by Fred Pennic 02/21/2018 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Emulate_Cedars-Sinai

Scientists at Cedars-Sinai and Boston-based digital health startup Emulate are pioneering a Patient-on-a-Chip program to help predict which disease treatments would be most effective based on a patient’s genetic makeup and disease variant—a new approach to advance precision medicine.

Researchers know that people respond differently to foods, drugs, and chemicals. For example, a medication may be effective in one individual, while it makes another even more ill. Until now, we’ve had no way to test how a diet or a treatment plan would affect a person before administering it to them.

The collaboration leverages innovative stem cell science from the Cedars-Sinai Board of Governors Regenerative Medicine Institute and Emulate’s Human Emulation System, which uses Organs-on-Chips technology to re-create true-to-life biology outside the body. This technology creates an environment where the cells exhibit an unprecedented level of biological function, and provides control of complex human biology and disease mechanisms not possible with existing techniques.

Cedars-Sinai, Emulate Partner on ‘Patient-on-a-Chip’ Program to Predict Disease Treatments

This Patient-on-a-Chip program holds the potential to advance the field of precision medicine and provide clinicians with a new system that more accurately predicts an individual’s response to foods, medicines, and chemicals.

The research points to a host of practical clinical applications that can benefit patients. By placing a patient’s cells in Organ-Chips and exposing those cells to a particular drug or series of drugs, clinicians could gain more accurate information about how that individual would respond to treatment, avoiding the risk of administering a drug that may cause harm or is ineffective and costly.

Emulate’s Human Emulation System — which is made up of Organs-on-Chips, instrumentation and software apps — re-creates the natural physiology cells experience within the body. Each chip, which is approximately the size of an AA battery, features tiny channels lined with tens of thousands of living human cells, recreating the smallest functional unit of an organ. Air and fluid, such as blood, can be passed through the chips, creating a micro-engineered environment that is a “home-away-from-home” for cells, where they behave just as they do in the body.

This project holds the potential to change the way diseases are treated. It will also change the way each of us understands and manages our own health by providing deeper insights into our own biology.

“By creating a personalized Patient-on-a-Chip, we can really begin to understand how diseases, medicines, chemicals and foods affect an individual’s health,” said Geraldine A. Hamilton, PhD, president and chief scientific officer of Emulate, Inc. in a statement. “The goal of Emulate working with Cedars-Sinai is to advance and qualify the system for new clinical applications and ultimately democratize the technology so that it can have broad impact on patient healthcare.”

In the future, a Patient-on-a-Chip also could be used to predict how a disease progresses in an individual, allowing for the design of personalized preventive medicine and treatment regimens to promote wellness and prevent disease, said Robert Barrett, PhD, an assistant professor of Medicine at Cedars-Sinai and senior author of the study in Cellular and Molecular Gastroenterology and Hepatology. Other applications include designing clinical trials to identify at-risk populations for adverse drug reactions.

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tagged With: Emulate, genomic precision medicine, Organs-on-Chips, Patient On A Chip, Precision Medicine

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Knowledge Hub

 How Top Health Plans Use AI to Save Money and Work Smarter How Top Health Plans Use AI to Save Money and Work Smarter

 How to Build Hybrid Care Models Around Remote Patient Monitoring How to Build Hybrid Care Models Around Remote Patient Monitoring

Trending

Cigna to Acquire Express Scripts for $67B: 5 Things to Know

Cigna and Humana Merger Talks Could Face Antitrust Scrutiny

RNSA23: Cleveland Clinic and Canon Partner to Pioneer Next-Gen Imaging Technologies

RSNA23: Cleveland Clinic and Canon to Establish Comprehensive Imaging Research Center

Automating Implant Orders: A Turning Point in Healthcare’s Digital Transformation

Automating Implant Orders: A Turning Point in Healthcare’s Digital Transformation

Consumers Believe Generative AI Can Revolutionize Healthcare

71% of Consumers Believe Generative AI Can Revolutionize Healthcare

NCQA Launches Virtual Care Accreditation Pilot

NCQA Launches Virtual Care Accreditation Pilot

Novant Health Acquires Three Tenet Hospitals in South Carolina for $2.4 Billion

M&A: Novant Health Acquires 3 Tenet Hospitals in South Carolina for $2.4B

UnitedHealthcare Launches Virtual Prescription Renewal Option

UnitedHealthcare Accused of Using Faulty AI Model to Deny Healthcare Claims to Elderly Patients

Meet The Circular Smart Ring Slim, The Slimmest and Lightest Smart Ring in the World

Meet The Circular Smart Ring Slim, The Slimmest and Lightest Smart Ring in the World

MIT Spun Out Layer Health Launches with $4M to Build the AI Layer for Healthcare

MIT Spun Out Layer Health Launches with $4M to Build the AI Layer for Healthcare

Edge Computing's Role in Shaping the Future of Wearable Healthcare

Edge Computing’s Role in Shaping the Future of Wearable Healthcare

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • 2023 Editorial Calendar
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2023. HIT Consultant Media. All Rights Reserved. Privacy Policy |